BlackRock Group Form 8.3 - Pfizer, Inc. (8239G)

TIDMPFZ

RNS Number : 8239G

BlackRock Group

24 November 2015

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY INFORMATION 
 
Name of person dealing      BlackRock, Inc. 
 (Note 1) 
==========================  ==================== 
Company dealt in            Pfizer, Inc. 
==========================  ==================== 
Class of relevant security  US$0.05 common stock 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
==========================  ==================== 
Date of dealing             23 November 2015 
==========================  ==================== 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                           Long                  Short 
===========================  ======================  ===================== 
                             Number            (%)    Number           (%) 
===========================  =========  ====  =====  =========  ====  ==== 
                                  395,701,728 
(1) Relevant securities              (6.41%)            516,078 (0.00%) 
===========================  ======================  ===================== 
(2) Derivatives (other 
 than options)                 1,362,576 (0.02%)        11,021 (0.00%) 
===========================  ======================  ===================== 
(3) Options and agreements                                21,200,800 
 to purchase/sell              20,000,000 (0.32%)           (0.34%) 
===========================  ======================  ===================== 
                                  417,064,304             21,727,899 
Total                                (6.76%)                (0.35%) 
===========================  ======================  ===================== 
 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
Class of relevant security:                Long                Short 
============================  ===================  ===================== 
                              Number          (%)   Number           (%) 
============================  =======  ====  ====  =========  ====  ==== 
(1) Relevant securities 
============================  ===================  ===================== 
 
  (2) Derivatives (other 
  than options) 
============================  ===================  ===================== 
 
  (3) Options and agreements 
  to purchase/sell 
============================  ===================  ===================== 
Total 
============================  ===================  ===================== 
 
 

Ap20

   1.       DEALINGS (Note 4) 
   (a)      Purchases and sales 
 
 
  Purchase/sale           Number of relevant securities        Price per unit 
                                                               (Note 5) 
===============  ======================================  ==================== 
Purchase         42,792                                  USD 31.3300 
===============  ======================================  ==================== 
Purchase         5,000                                   USD 31.4000 
===============  ======================================  ==================== 
Purchase         530,116                                 USD 31.4277 
===============  ======================================  ==================== 
Purchase         213,044                                 USD 31.4381 
===============  ======================================  ==================== 
Purchase         4,403                                   USD 31.5228 
===============  ======================================  ==================== 
Sale             417,113                                 USD 31.2772 
===============  ======================================  ==================== 
Sale             73,490                                  USD 31.3300 
===============  ======================================  ==================== 
Sale             38,100                                  USD 31.3526 
===============  ======================================  ==================== 
 

Please note: there was also a Transfer In of 176,474 Shares.

   (b)      Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant   Price per 
 name,      (Note 6)               securities           unit 
 e.g. CFD                          (Note 7)             (Note 5) 
=========  =====================  ==================  =========== 
CFD        Reducing Long          761                 USD 31.2795 
=========  =====================  ==================  =========== 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
==========  ============  ==============  ========  ===============  ======  ==================== 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5) 
=================  ===========================  =================== 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 4) 
 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5) 
=====================  ==============  ==================== 
Return of stock        32,700          N/A 
 on loan 
=====================  ==============  ==================== 
 

Ap21

   2.       OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none,

this should be stated.

None

   Is a Supplemental Form 8 attached? (Note 9)                                    YES 
 
Date of disclosure            24 November 2015 
============================  ================ 
Contact name                  Tim Dudley 
============================  ================ 
Telephone number              [phone] 
============================  ================ 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
============================  ================ 
If a connected EFM, state 
 nature of connection (Note 
 10) 
============================  ================ 
 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

 
 Product      Written,        Number of relevant     Exercise     Type, e.g.   Expiry 
  name,        or purchased    securities             price        American,    date 
  e.g. call                    to which the           (Note        European 
  option                       option or derivative   2)           etc. 
                               relates 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         110,200                 USD 34.0000  American    04/12/2015 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         186,000                 USD 34.5000  American    04/12/2015 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Purchased       20,000,000              USD 34.5000  American    04/12/2015 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         299,400                 USD 35.0000  American    04/12/2015 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         270,000                 USD 34.0000  American    18/12/2015 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         110,200                 USD 35.0000  American    18/12/2015 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         20,000,000              USD 37.5000  American    15/01/2016 
===========  ==============  ======================  ===========  ==========  ========== 
Call Option  Written         225,000                 USD 34.0000  American    15/01/2016 
===========  ==============  ======================  ===========  ==========  ========== 
 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

   2.          For all prices and other monetary amounts, the currency must be stated. 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

This information is provided by RNS

(MORE TO FOLLOW) Dow Jones Newswires

November 24, 2015 10:19 ET (15:19 GMT)